These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19404928)

  • 1. Tocilizumab and missed personalized medicine opportunities for patients with rheumatoid arthritis?
    Littman BH
    Arthritis Rheum; 2009 May; 60(5):1565-6. PubMed ID: 19404928
    [No Abstract]   [Full Text] [Related]  

  • 2. Tocilizumab for rheumatoid arthritis.
    Drug Ther Bull; 2010 Jan; 48(1):9-12. PubMed ID: 20040568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab (Actemra) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2010 Jun; 52(1340):47-8. PubMed ID: 20539266
    [No Abstract]   [Full Text] [Related]  

  • 4. [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)].
    Nasonov EL
    Ter Arkh; 2010; 82(5):64-71. PubMed ID: 20597275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approves tocilizumab to treat rheumatoid arthritis.
    Thompson CA
    Am J Health Syst Pharm; 2010 Feb; 67(4):254. PubMed ID: 20133526
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks.
    Yokoe I; Nishio S; Sato H; Kobayashi H
    Mod Rheumatol; 2011 Dec; 21(6):710-4. PubMed ID: 21656090
    [No Abstract]   [Full Text] [Related]  

  • 7. Additional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis.
    Mori S
    Mod Rheumatol; 2012 Nov; 22(6):947-50. PubMed ID: 22350573
    [No Abstract]   [Full Text] [Related]  

  • 8. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
    Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rheumatoid arthritis and ankylosing spondylitis-rheumatologic highlights 2009].
    Dudler J
    Rev Med Suisse; 2010 Jan; 6(232):141-2, 144. PubMed ID: 20170034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of rheumatoid arthritis with adalimumab. Results from a Cochrane review].
    Pedersen SJ; Hetland ML; Østergaard M
    Ugeskr Laeger; 2006 Aug; 168(35):2899-903. PubMed ID: 16982019
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant DNA product for rheumatoid arthritis.
    FDA Consum; 2003; 37(2):5. PubMed ID: 12715755
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adalimumab slows the progression of rheumatoid arthritis].
    Pharm Unserer Zeit; 2003; 32(1):75-6. PubMed ID: 12577764
    [No Abstract]   [Full Text] [Related]  

  • 13. Adalimumab for rheumatoid arthritis?
    Ebell M; Kripke C
    Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologic agents for rheumatoid arthritis: 2008 and beyond.
    Sweiss NJ; Hushaw LL
    J Infus Nurs; 2009; 32(1 Suppl):S4-17; quiz S19-24. PubMed ID: 19142153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
    Nagashima T; Minota S
    J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
    Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
    Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 inhibition--tolerability profile and clinical implications.
    Strand V; Yazici Y
    Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S21-4. PubMed ID: 17708741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adalimumab in advanced and early rheumatoid arthritis].
    Szekanecz Z
    Orv Hetil; 2009 Jul; 150(28):1333-4. PubMed ID: 19581162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Danish data document therapeutic effect differences of tumor necrosis factor inhibitors in patient with rheumatoid arthritis].
    Hetland ML
    Ugeskr Laeger; 2010 Jun; 172(26):2003; author reply 2003-4. PubMed ID: 20681045
    [No Abstract]   [Full Text] [Related]  

  • 20. New therapies for treatment of rheumatoid arthritis.
    Smolen JS; Aletaha D; Koeller M; Weisman MH; Emery P
    Lancet; 2007 Dec; 370(9602):1861-74. PubMed ID: 17570481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.